ACE2 and neuroblastoma: Among the glioblastoma/neuroblastoma cell lines, the permissive MGB4114 and MGB6138 were also characterized by increased expression of ACE2 (4.9 and 1.4% of GUS mRNA, respectively), compared to low expression for the majority of non-permissive cell lines (0.09–1% in general).